Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis
Oncology · 2024
DOI: 10.1159/000540515 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology, 2024. Verfasst von Franziska Maria Kraus und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany, franzi_kraus@gmx.de. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Thyroid Nuclear Factor 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Introduction
Pulmonary adenocarcinoma with enteric differentiation (PAED) without thyroid transcription factor-1 (TTF-1) expression is an extremely rare variant of lung cancer. Due to its rarity, few clinicopathological and molecular studies have been performed on PAED, particularly in Caucasian patients. Therefore, it is necessary to obtain clinicopathological data of Caucasian PAED patients without TTF-1 expression, their systemic therapy options, and the efficacy of their systemic treatment.
Methods
We examined the clinicopathological features of 121 cases of TTF-1-negative pulmonary adenocarcinoma at a certified German lung cancer center including 79 cases without a PAED and 42 cases with a PAED, compared these subgroups, and investigated patients’ response to chemotherapy and immunotherapy as first-line treatment. By using endoscopy and/or a PET-CT, a primary adenocarcinoma of the digestive tract was excluded in all PAED patients.
Results
A comparison of clinicopathological data of TTF-1-negative PAED and non-PAED patients revealed a significantly lower frequency of high programmed death receptor ligand 1 (PD-L1) expression in PAED resulting in the lack of single-agent immunotherapy (p = 0.032) in this subgroup. Frequencies of an activating Kirsten rat sarcoma viral oncogene homolog (KRAS) gene mutation were high in both groups (46.7% and 50.0%), but G12C gene mutations were seldomly noted (in 6.7% and 18.5% of patients with evaluable data). Median overall survival (OS) was poor in both groups (10 and 12 months). The majority of PAED patients received platinum-based and taxane-containing chemotherapy or chemo-/immunotherapy with an objective response rate (ORR) of 31.6% and a disease control rate of 57.9%. Median progression-free survival (PFS) and OS of PAED patients with systemic therapy were very poor (3.9 months and 5.9 months).
Conclusions
Caucasian patients with TTF-1 negative PAED have a poor prognosis with a reduced ORR to standard first-line systemic therapy and short survival times (PFS and OS).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany, franzi_kraus@gmx.de.
- Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
- Department of Pneumology, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
- Germany and University Hospital Witten-Herdecke, Witten, Germany.
- Department of Thoracic Surgery, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Essen, Germany.
- Practice for Radio-Oncology Essen, Essen, Germany.
Zitieren
APA
Kraus, F. M., Traut, A., Nilius, G., Volmerig, J., Koziorowski, A., Stöver, I., Grabellus, F., Stahl, M., & Christoph, D. C. (2024). Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis. Oncology. https://doi.org/10.1159/000540515
Vancouver
Kraus FM, Traut A, Nilius G, Volmerig J, Koziorowski A, Stöver I, et al. Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis. Oncology. 2024. doi:10.1159/000540515
BibTeX
@article{Kraus2024,
author = {Kraus, Franziska Maria and Traut, Alexander and Nilius, Georg and Volmerig, Jan and Koziorowski, Andreas and Stöver, Imke and Grabellus, Florian and Stahl, Michael and Christoph, Daniel C},
title = {Pulmonary Adenocarcinoma with Enteric Differentiation without TTF-1 Expression Is a Very Rare Subtype with Limited Treatment Options and Poor Prognosis},
journal = {Oncology},
year = {2024},
doi = {10.1159/000540515}
}
EUVIMED